Gino Santini

3.1k total citations
86 papers, 2.0k citations indexed

About

Gino Santini is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Gino Santini has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pathology and Forensic Medicine, 24 papers in Genetics and 24 papers in Oncology. Recurrent topics in Gino Santini's work include Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Lymphoblastic Leukemia research (19 papers). Gino Santini is often cited by papers focused on Lymphoma Diagnosis and Treatment (35 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Lymphoblastic Leukemia research (19 papers). Gino Santini collaborates with scholars based in Italy, United States and United Kingdom. Gino Santini's co-authors include Teodoro Chisesi, E Damasio, Anthony H. Goldstone, S Nati, A Congiu, Angelo Michele Carella, Giuseppe Famularo, Sonia Moretti, G. Taghipour and Sonia Marcellini and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and Cancer.

In The Last Decade

Gino Santini

83 papers receiving 1.9k citations

Peers

Countries citing papers authored by Gino Santini

Since Specialization

Citations

This map shows the geographic impact of Gino Santini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gino Santini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gino Santini more than expected).

Fields of papers citing papers by Gino Santini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gino Santini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gino Santini. The network helps show where Gino Santini may publish in the future.

Co-authorship network of co-authors of Gino Santini

This figure shows the co-authorship network connecting the top 25 collaborators of Gino Santini. A scholar is included among the top collaborators of Gino Santini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gino Santini. Gino Santini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complementary therapies for treating alcoholism 2007 ·Fitoterapia ·Ludovico Abenavoli, (unknown), (unknown), (unknown), Gino Santini, (unknown), (unknown), Lorenzo Leggio, Giovanni Addolorato	10
2	Fludarabine, Cyclophosphamide and Mitoxantrone for Untreated Follicular Lymphoma: a Report from the Non-Hodgkin's Lymphoma Co-operative Study Group 2004 ·Leukemia & lymphoma ·Gino Santini, Teodoro Chisesi, S Nati, Adolfo Porcellini, Valerio Zoli, Vittorio Rizzoli, Simona Zupo, (unknown), A. Rubagotti, (unknown), Mauro Spriano, R. Vimercati, A Congiu, Jean Louis Ravetti, Savina Aversa, Marco Candela, Caterina Patti	7
3	An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation 2003 ·Bone Marrow Transplantation ·Andy Peniket, M C Ruiz de Elvira, G. Taghipour, Catherine Cordonnier, Éliane Gluckman, T de Witte, Gino Santini, Didier Blaise, Hildegard Greinix, Augustin Ferrant, Jan J. Cornelissen, Norbert Schmitz, Anthony H. Goldstone, (unknown)	225
4	Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula 2002 ·Biochemical Pharmacology ·Luciana Mosca, Sonia Marcellini, Marzia Perluigi, (unknown), Sonia Moretti, Giuseppe Famularo, Ilaria Peluso, Gino Santini, (unknown)	25
5	ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial 2002 ·Annals of Oncology ·Teodoro Chisesi, Massimo Federico, Alessandro Levis, (unknown), (unknown), Gino Santini, Stefano Luminari, (unknown)	32
6	Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma. 2001 ·CINECA IRIS Institutial Research Information System (University of Genoa) ·Gino Santini, S Nati, Mauro Spriano, Andrea Gallamini, (unknown), (unknown), Mauro Truini, A. Rubagotti, Teodoro Chisesi, R. Vimercati, E. Rossi, (unknown), Daniele Mattei, Gloria E. Marino, Marco Gobbi	24
7	High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors 2001 ·Cancer ·Andrea Banfi, (unknown), Laura Fazzuoli, Mario Roberto Sertoli, Marco Venturini, Gino Santini, Ranieri Cancedda, Rodolfo Quarto	106
8	Cemp, A Mitoxantrone Containing Combination, in the Treatment of Intermediate and High Grade Non-Hodgkin's Lymphoma: an Effective and Non Toxic Therapeutic Alternative for Adult and Elderly Patients: On behalf of Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG) 2001 ·Leukemia & lymphoma ·Teodoro Chisesi, P. Polistena, A. Contu, P Coser, (unknown), Pietro Leoni, Ignazio Majolino, Antonio Porcellini, Luigi Salvagno, (unknown), Vittorio Rizzoli, A Congiu, Gino Santini	2
9	Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia 1999 ·Franco Mandelli, F. Lauria, Ignazio Majolino, G Meloni, Gino Santini, Robin Foà, Gianluigi Castoldi, Paolo Corradini, Brunangelo Falini, Stefano Pileri, Vincenzo Liso	2
10	Reduction of Glutamate Levels in HIV-Infected Subjects Treated with Acetylcarnitine 1999 ·PubMed ·Giuseppe Famularo, Sonia Moretti, Edoardo Alesse, Vito Trinchieri, Adriano Angelucci, Gino Santini, Maria Grazia Cifone, (unknown)	2
11	High-Dose Cyclophosphamide Followed by Autografting Can Improve the Outcome of Relapsed or Resistant Non-Hodgkin's Lymphomas with Involved or Hypoplastic Bone Marrow 1999 ·Leukemia & lymphoma ·Gino Santini, Cármino Antônio De Souza, A Congiu, S Nati, (unknown), Monica Soracco, Mario Roberto Sertoli, A. Rubagotti, Mauro Spriano, F. Vassallo, Edoardo Rossi, R. Vimercati, Giovanna Piaggio, O Figari, Federica Benvenuto, (unknown), Mauro Truini, Jean Louis Ravetti, (unknown), E Damasio	7
12	First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease 1998 ·European Journal Of Haematology ·Marino Clavio, María Angélica Miglino, Mauro Spriano, Daniela Pietrasanta, (unknown), (unknown), Letizia Canepa, Ivana Pierri, (unknown), Filippo Ballerini, Giovanni Beltrami, E. Rossi, R. Vimercati, Renato Bruni, M. Congiu, S Nati, E Damasio, Gino Santini, Marco Gobbi	22
13	Mobilizatiod/Transplantation of Peripheral Blood Progenitor Cells for Aggressive Non-Hodgkin's Lymphoma with Marrow Involvement 1997 ·Leukemia & lymphoma ·Gino Santini, (unknown), S Nati, Letizia Canepa, Mauro Spriano, Teodoro Chisesi, (unknown), R. Vimercati, (unknown), O Figari, Marco Gobbi, Giovanna Piaggio, F. Vassallo, Federica Benvenuto, Monica Soracco, María Angélica Miglino, Jean Louis Ravetti, Mauro Truini	10
14	Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. 1996 ·Journal of Clinical Oncology ·C. D. Williams, A. H. Goldstone, R Pearce, Thierry Philip, Oliver Hartmann, P Colombat, Gino Santini, (unknown), Norbert Claude Gorin	83
15	Anaplastic Large Cell Lymphoma: A Clinicopathologic Study of 53 Patients 1996 ·Leukemia & lymphoma ·Marino Clavio, E. Rossi, (unknown), Paola Carrara, (unknown), Mauro Spriano, Antonella Vimercati, Gino Santini, Letizia Canepa, Ivana Pierri, (unknown), María Angélica Miglino, A. Castellaneta, E Damasio, Marco Gobbi	32
16	MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. 1994 ·Journal of Clinical Oncology ·M.R. Sertoli, Gino Santini, Teodoro Chisesi, A Congiu, A. Rubagotti, A. Contu, Luigi Salvagno, P Coser, Antonio Porcellini, Michele Vespignani	31
17	High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. 1994 ·Journal of Clinical Oncology ·John Sweetenham, (unknown), R Pearce, G. Taghipour, Gino Santini, Anthony H. Goldstone	52
18	Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First Remission 1991 ·Leukemia & lymphoma ·Angelo Michele Carella, S Nati, P. Carlier, (unknown), Domenico Giordano, A Congiu, Gino Santini, D Scarpati, Salvina Barra, Renzo Corvò, Vito Vitale, (unknown), R Cerri, Marco Risso, Mauro Spriano, R. Vimercati, Ester Pungolino, Andrea Bacigalupo, E Damasio	3
19	Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: An interim report of a randomized study 1991 ·European Journal of Cancer and Clinical Oncology ·Teodoro Chisesi, (unknown), A. Contu, P Coser, Luciano Moretti, Adolfo Porcellini, (unknown), Luigi Salvagno, Gino Santini, Orazio Vinante	22
20	A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia 1990 ·Leukemia & lymphoma ·Angelo Michele Carella, (unknown), (unknown), S Nati, (unknown), Gino Santini, Domenico Giordano, R Cerri, Marco Risso, Edoardo Rossi, Mauro Spriano, (unknown), P. Carlier, (unknown), (unknown), Andrea Bacigalupo, Alberto M. Marmont	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact